Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Creatine supplementation and resistance training to preserve muscle mass and attenuate cancer progression (CREATINE-52): a protocol for a double-blind randomized controlled trial

Fig. 2

Study Schematic. *Randomization will be in blocks of size four (two per group), stratified by age (< 70 years vs. ≥ 70 years) and ECOG performance status (0,1,2). Cr + RT: Creatine monohydrate supplementation & Resistance Training; PLA + RT: Placebo and Resistance Training; g: Grams

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us